日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern

SARS-CoV-2 替代中和试验的验证,检测针对主要关注变异株的中和抗体

Eveline Santos da Silva, Jean-Yves Servais, Michel Kohnen, Vic Arendt, Therese Staub, The Con-Vince Consortium, The CoVaLux Consortium, Rejko Krüger, Guy Fagherazzi, Paul Wilmes, Judith M Hübschen, Markus Ollert, Danielle Perez-Bercoff, Carole Seguin-Devaux

Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples

基于纳米荧光素酶的细胞融合检测可快速高通量评估患者样本中的 SARS-CoV-2 中和抗体

Max Meyrath, Martyna Szpakowska, Jean-Marc Plesseria, Olivia Domingues, Jérémie Langlet, Bernard Weber, Rejko Krüger, Markus Ollert, Andy Chevigné; CON-VINCE Consortium